PCN42 Budget Impact Analysis of the Oncotype DX Breast Cancer Recurrence Score Test to Guide Chemotherapy Use in ER+/HER2- Node-Negative Early Invasive Breast Cancer

Autor:	S. Millen, N. Fryer, L. Floros, N. Georges, J. Griffin, V. Berdunov, S. Reynia, A. Paramore
Rok vydání:	2021
Předmět:	Score test Oncology medicine.medical_specialty Chemotherapy medicine.diagnostic_test Breast cancer recurrence business.industry Health Policy medicine.medical_treatment Public Health Environmental and Occupational Health Budget impact medicine.disease Node negative Breast cancer Internal medicine medicine Oncotype DX business
Zdroj:	Value in Health. 24:S26
ISSN:	1098-3015
DOI:	10.1016/j.jval.2021.04.134
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::20a02b78b97842be94bd4104e7a2dfe1 https://doi.org/10.1016/j.jval.2021.04.134 Zobrazit plný text záznamu Full Text from ScienceDirect